EP 1395260 A1 20040310 - USE OF THE OPIOID ANTAGONIST NALTREXONE TO PREVENT AND CONTROL SIDE EFFECTS CAUSED BY OPIOIDS
Title (en)
USE OF THE OPIOID ANTAGONIST NALTREXONE TO PREVENT AND CONTROL SIDE EFFECTS CAUSED BY OPIOIDS
Title (de)
VERWENDUNG DES OPIOID-ANTAGONISTEN NALTREXON ZUR VORBEUGUNG UND KONTROLLE DER DURCH OPIOIDE VERURSACHTEN NEBENEFFEKTE
Title (fr)
UTILISATION DE L'ANTAGONISTE OPIOIDE NALTREXONE DANS LA PREVENTION ET LE CONTROLE DES EFFETS SECONDAIRES CAUSES PAR LES OPIOIDES
Publication
Application
Priority
- IB 0201473 W 20020502
- IT MI20010907 A 20010502
Abstract (en)
[origin: WO02087582A1] Use of naltrexone to prepare pharmaceutical compositions suitable to prevent and control the side effects caused by the treatment with morphine, to be administered by mouth in the dose ranging between 0,01 and 0,9 mg/mg of administered morphine.
IPC 1-7
IPC 8 full level
A61K 9/16 (2006.01); A61K 9/48 (2006.01); A61K 31/485 (2006.01); A61P 25/04 (2006.01)
CPC (source: EP)
A61K 9/1676 (2013.01); A61K 9/4808 (2013.01); A61K 31/485 (2013.01); A61P 25/04 (2018.01)
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
DOCDB simple family (publication)
WO 02087582 A1 20021107; EP 1395260 A1 20040310; IT MI20010907 A0 20010502; IT MI20010907 A1 20021102; RU 2003135201 A 20050327; ZA 200309333 B 20040217
DOCDB simple family (application)
IB 0201473 W 20020502; EP 02726358 A 20020502; IT MI20010907 A 20010502; RU 2003135201 A 20020502; ZA 200309333 A 20031201